280 related articles for article (PubMed ID: 23561304)
21. Clinically meaningful improvement in symptoms and quality of life for patients with non-small-cell lung cancer receiving gefitinib in a randomized controlled trial.
Cella D; Herbst RS; Lynch TJ; Prager D; Belani CP; Schiller JH; Heyes A; Ochs JS; Wolf MK; Kay AC; Kris MG; Natale RB
J Clin Oncol; 2005 May; 23(13):2946-54. PubMed ID: 15699477
[TBL] [Abstract][Full Text] [Related]
22. Improvements in quality of life and disease-related symptoms in phase I trials of the selective oral epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in non-small cell lung cancer and other solid tumors.
LoRusso PM; Herbst RS; Rischin D; Ranson M; Calvert H; Raymond E; Kieback D; Kaye S; Gianni L; Harris A; Bjork T; Maddox AM; Rothenberg ML; Small EJ; Rubin EH; Feyereislova A; Heyes A; Averbuch SD; Ochs J; Baselga J
Clin Cancer Res; 2003 Jun; 9(6):2040-8. PubMed ID: 12796366
[TBL] [Abstract][Full Text] [Related]
23. How best to assess the quality of life in long-term survivors after surgery for NSCLC? Comparison between clinical predictors and questionnaire scores.
Sterzi S; Cesario A; Cusumano G; Corbo G; Lococo F; Biasotti B; Lapenna LM; Magrone G; Dall'armi V; Meacci E; Porziella V; Bonassi S; Margaritora S; Granone P
Clin Lung Cancer; 2013 Jan; 14(1):78-87. PubMed ID: 22607778
[TBL] [Abstract][Full Text] [Related]
24. The humanistic burden of advanced non-small cell lung cancer (NSCLC) in Europe: a real-world survey linking patient clinical factors to patient and caregiver burden.
Wood R; Taylor-Stokes G; Smith F; Chaib C
Qual Life Res; 2019 Jul; 28(7):1849-1861. PubMed ID: 30825160
[TBL] [Abstract][Full Text] [Related]
25. Tumor response and health-related quality of life in clinically selected patients from Asia with advanced non-small-cell lung cancer treated with first-line gefitinib: post hoc analyses from the IPASS study.
Wu YL; Fukuoka M; Mok TS; Saijo N; Thongprasert S; Yang JC; Chu DT; Yang JJ; Rukazenkov Y
Lung Cancer; 2013 Aug; 81(2):280-7. PubMed ID: 23540718
[TBL] [Abstract][Full Text] [Related]
26. Doxetaxel in previously treated non-small cell lung cancer patients: clinical efficacy and quality of life.
Sirisinha T; Sirilertrakul S; Jirajarus M; Ratanatharathorn V
Southeast Asian J Trop Med Public Health; 2005 Jan; 36(1):246-53. PubMed ID: 15906678
[TBL] [Abstract][Full Text] [Related]
27. Health-related quality of life in lung cancer patients in Serbia: correlation with socio-economic and clinical parameters.
Maric D; Jovanovic D; Golubicic I; Dimic S; Pekmezovic T
Eur J Cancer Care (Engl); 2010 Sep; 19(5):594-602. PubMed ID: 20030692
[TBL] [Abstract][Full Text] [Related]
28. Quality of life, symptom status and physical performance in patients with advanced non-small cell lung cancer undergoing chemotherapy: an exploratory analysis of secondary data.
Shallwani SM; Simmonds MJ; Kasymjanova G; Spahija J
Lung Cancer; 2016 Sep; 99():69-75. PubMed ID: 27565917
[TBL] [Abstract][Full Text] [Related]
29. Symptom experiences and health-related quality of life among non-small cell lung cancer patients participating in clinical trials.
Lee K; Oh EG; Kim S; Kim SW
J Clin Nurs; 2019 Jun; 28(11-12):2111-2123. PubMed ID: 30667122
[TBL] [Abstract][Full Text] [Related]
30. Relationship between symptom change, objective tumor measurements, and performance status during chemotherapy for advanced lung cancer.
Cella D; Eton D; Hensing TA; Masters GA; Parasuraman B
Clin Lung Cancer; 2008 Jan; 9(1):51-8. PubMed ID: 18282359
[TBL] [Abstract][Full Text] [Related]
31. Health-related quality of life in patients with pancreatic cancer.
Müller-Nordhorn J; Roll S; Böhmig M; Nocon M; Reich A; Braun C; Noesselt L; Wiedenmann B; Willich SN; Brüggenjürgen B
Digestion; 2006; 74(2):118-25. PubMed ID: 17191029
[TBL] [Abstract][Full Text] [Related]
32. [Quality of life after lobectomy for early stage non-small cell lung cancer--video-assisted thoracoscopic surgery versus minimal incision thoracotomy].
Long H; Lin ZC; Lin YB; Situ DR; Wang YN; Rong TH
Ai Zheng; 2007 Jun; 26(6):624-8. PubMed ID: 17562269
[TBL] [Abstract][Full Text] [Related]
33. Patient-reported impact of urinary incontinence--results from treatment seeking women in 14 European countries.
Monz B; Pons ME; Hampel C; Hunskaar S; Quail D; Samsioe G; Sykes D; Wagg A; Papanicolaou S
Maturitas; 2005 Nov; 52 Suppl 2():S24-34. PubMed ID: 16297579
[TBL] [Abstract][Full Text] [Related]
34. Health-related quality of life in colorectal cancer.
Färkkilä N; Sintonen H; Saarto T; Järvinen H; Hänninen J; Taari K; Roine RP
Colorectal Dis; 2013 May; 15(5):e215-22. PubMed ID: 23351057
[TBL] [Abstract][Full Text] [Related]
35. Hypofractionated palliative radiotherapy (17 Gy per two fractions) in advanced non-small-cell lung carcinoma is comparable to standard fractionation for symptom control and survival: a national phase III trial.
Sundstrøm S; Bremnes R; Aasebø U; Aamdal S; Hatlevoll R; Brunsvig P; Johannessen DC; Klepp O; Fayers PM; Kaasa S
J Clin Oncol; 2004 Mar; 22(5):801-10. PubMed ID: 14990635
[TBL] [Abstract][Full Text] [Related]
36. Quality of life and utility in patients with non-small cell lung cancer. Quality-of-life Study Group of the Master 2 Project in Pharmacoeconomics.
Trippoli S; Vaiani M; Lucioni C; Messori A
Pharmacoeconomics; 2001; 19(8):855-63. PubMed ID: 11596837
[TBL] [Abstract][Full Text] [Related]
37. Measuring quality of life: an emerging science.
Moinpour CM
Semin Oncol; 1994 Oct; 21(5 Suppl 10):48-60; discussion 60-3. PubMed ID: 7973770
[TBL] [Abstract][Full Text] [Related]
38. Phase II study: integrated palliative care in newly diagnosed advanced non-small-cell lung cancer patients.
Temel JS; Jackson VA; Billings JA; Dahlin C; Block SD; Buss MK; Ostler P; Fidias P; Muzikansky A; Greer JA; Pirl WF; Lynch TJ
J Clin Oncol; 2007 Jun; 25(17):2377-82. PubMed ID: 17557950
[TBL] [Abstract][Full Text] [Related]
39. Is voluntary vitamin and mineral supplementation associated with better outcome in non-small cell lung cancer patients? Results from the Mayo Clinic lung cancer cohort.
Jatoi A; Williams B; Nichols F; Marks R; Aubry MC; Wampfler J; Finke EE; Yang P
Lung Cancer; 2005 Jul; 49(1):77-84. PubMed ID: 15949593
[TBL] [Abstract][Full Text] [Related]
40. Observational Prospective Study to Determine the Evolution of the Symptomatic Profile of Metastatic Non-Small Cell Lung Cancer (NSCLC) Patients and Its Relation to the Control of the Disease.
Dómine M; Massuti B; Puente J; Calles A; Esteban E; Triguboff E; Afonzo YS; Gironés R; Aparisi F; Oramas J
Adv Ther; 2019 Jun; 36(6):1497-1508. PubMed ID: 30963512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
